Natural regulatory T cells control coronary arteriolar endothelial dysfunction in hypertensive mice by 理쒖닔寃�
The American Journal of Pathology, Vol. 178, No. 1, January 2011
Copyright © 2011 American Society for Investigative Pathology.
Published by Elsevier Inc. All rights reserved.
DOI: 10.1016/j.ajpath.2010.11.034Vascular Biology, Atherosclerosis, and Endothelium Biology
Natural Regulatory T Cells Control Coronary Arteriolar
Endothelial Dysfunction in Hypertensive MiceKhalid Matrougui, PhD,*
Abd Elmageed Zakaria, PhD,*
Modar Kassan, PhD,* Sookyoung Choi, PhD,*
Devika Nair, MD,*
Romer A. Gonzalez-Villalobos, MD, PhD,*
Aziz A. Chentoufi, PhD,† Philip Kadowitz, PhD,‡
Souad Belmadani, PhD,§
and Megan Partyka, MS*
From the Departments of Physiology,* Pharmacology,‡
Hypertension and Renal Center of Excellence, Tulane University,
New Orleans, Louisiana; the Cellular and Molecular Immunology
Laboratory,† University of California Irvine Medical Center,
Orange, California; and the Department of Pathology,§ Louisiana
State University Health Science Center, New Orleans, Louisiana
Coronary artery disease in patients with hypertension
is increasing worldwide and leads to severe cardiovas-
cular complications. The cellular and molecular
mechanisms that underlie this pathologic condition
are not well understood. Experimental and clinical
research indicates that immune cells and inflamma-
tion play a central role in the pathogenesis of cardio-
vascular diseases. Recently, it has been reported that
CD4CD25 regulatory T cells (Tregs) regulate heart
fibrosis in hypertension. In this study, we determined
the role of Tregs in coronary arteriolar endothelial dys-
function in angiotensin II–dependent hypertensive
mice. Mice infused with angiotensin II had significantly
increased blood pressure, as determined using teleme-
try, and apoptotic Treg numbers, as measured using
flow cytometry. The mice displayed inflammation, as-
sessed by macrophage activation/infiltration into coro-
nary arterioles and the heart, and increased local tumor
necrosis factor- release, which participates in reduced
coronary arteriolar endothelial-dependent relaxation in
response to acetylcholine using an arteriograph. Hyper-
tensive mice injected with Tregs isolated from control
mice had significantly reduced macrophage activation
and infiltration, reduced tumor necrosis factor- re-
lease, and improved coronary arteriolar endothelium-
dependent relaxation. Our novel data indicate that
Tregs are important in the development of coronary
arteriolar endothelial dysfunction in hypertension.
434These results suggest a new direction in the investiga-
tion of vascular disease in hypertension and could lead
to a therapeutic strategy that involves immune system
modulation using Tregs. (Am J Pathol 2011, 178:434–441;
DOI: 10.1016/j.ajpath.2010.11.034)
Hypertension is still a major cause of morbidity and mor-
tality in the world. Endothelial dysfunction is considered
an early indicator of cardiovascular risk factors, such as
hypercholesterolemia, diabetes mellitus, smoking, and
hypertension. We and other investigators demonstrated
endothelial dysfunction in mesenteric resistance arter-
ies1–4 and coronary arterioles in hypertensive (HT) animal
models5 caused by a reduction in the relaxing factors
nitric oxide, prostaglandin I2, and endothelial-derived hy-
perpolarizing factor. Recent evidence highlights the in-
volvement of inflammation as a critical pathologic factor
in cardiovascular diseases.6–8 In addition, an increasing
body of data suggest that an imbalance in the immune
system triggers inflammation, and this could represent an
important and highly promising new direction for modify-
ing cardiovascular pathophysiologic effects.9–12 There-
fore, it is likely that microvascular endothelial dysfunction
in hypertension could be the result of perturbation in the
immune system and inflammation.
Regulatory T cells (Tregs), generally characterized by
the expression of CD4, CD25, and Foxp3, develop in the
thymus, identify specific self-antigen, and play a critical
role in maintaining self-tolerance and protection from au-
toimmune diseases13–16 and in affecting immune re-
sponses to different pathogens. This leads to new in-
sights into mechanisms of tolerance breakdown in human
diseases, including those resulting from allergic, autoim-
mune, or infectious causes.17,18 Experimental studies
and successful clinical trials advanced the concept that
Tregs are important as a therapy for type 1 diabetes
mellitus.
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angiotensin II (Ang II) may contribute to the pathogenesis
of hypertensive kidney disease,19,20 suggesting a critical
role for the immune system in the pathogenesis of hyper-
tension. A recent study indicates that Tregs play a key
role in the regulation of arterial wall disease, especially
atherosclerosis. Thus, increased Treg numbers have
been shown to be powerful inhibitors of atherosclerosis in
several mouse models.12 Recently, it has been reported
that T cells play an important role in the genesis of hy-
pertension.21,22 Mice lacking T and B cells (Rag1/
mice) do not develop hypertension and abnormalities of
vascular function during Ang II infusion.21 Note that there
are fundamental differences in function and structure be-
tween large and small arteries.23 Recently, it has been
reported that Tregs reverse hypertension-induced heart
damage.24 Thus, the overall goal of our study is to eluci-
date a new pathway for the pathogenesis of hypertension
and coronary arteriolar endothelial dysfunction involving
Tregs and inflammatory processes that are macrophage
dependent.
Materials and Methods
Animals and Telemetry
All the protocols were approved by the Tulane University
Health Sciences Center Animal Care and Use Commit-
tee. Mice (C57BL/6J, 8-week-old males) were purchased
from The Jackson Laboratory (Bar Harbor, ME) and were
maintained in a temperature-controlled room on a 12:12-
hour light-dark cycle with free access to food (sodium ion
content, 0.4%) and water.
Mice were subjected to isoflurane anesthesia, and a
catheter connected to a radiotelemetry device was in-
serted into the left carotid artery to monitor blood pres-
sure using telemetry in conscious, unrestrained mice
(model PA-C10; Data Sciences International, St. Paul,
MN).25,26 After a 5-day recovery phase, baseline mean
arterial pressure levels were measured, and the animals
were again subjected to general anesthesia for osmotic
mini-pump implantation. Data were collected, stored, and
analyzed using Dataquest A.R.T 4.0 software (Data Sci-
ences International). Mice were infused with Ang II (400
ng/kg/min) through subcutaneous mini-osmotic pumps
and then received, through i.p. injection, isolated and
purified Tregs (200,000 cells) from control mice three
times a week for 2 weeks. On day 14, the animals were
given isoflurane, and the spleen, macrophages, and
heart were collected.
Coronary Arteriolar Function
Septal arterioles (60 to 80 m in diameter) were isolated,
and endothelial function was measured as previously
described.27,28 Coronary arteriolar endothelium-depen-
dent relaxation was investigated in sham mice  Tregs
and in HT mice  Tregs or CD4 T cells. Endothelium-
dependent relaxation was also determined after the inhi-
bition of endothelial nitric oxide synthase (eNOS) with 100
mol/L NG-nitro-L-arginine-methyl ester (L-NAME).Isolated and Cultured Tregs
In Vivo Studies
Six C57Bl/6 mice were sacrificed, and the spleens
were isolated, dissected, and washed with cold and ster-
ile PBS. The spleens were cut into small pieces and were
strained using a 40-m cell strainer (BD Falcon, Fisher
Scientific, Pittsburgh, PA). A single cell suspension from
all the mice was prepared and then incubated with 0.85%
ammonium chloride–Tris-hydrochloride buffer to destroy
red blood cells. The cells were washed and then incu-
bated for 30 minutes with antimouse CD4/L3T4–fluores-
cein isothiocyanate, antimouse CD25/interleukin-2 (IL-2)
receptor –phosphatidylethanolamine and using rat
IgG2b–phosphatidylethanolamine as a positive clone (all
from Beckman Coulter Inc., Brea, CA). Treg-stained cells
were washed with sterile PBS and were passed through a
Becton Dickinson (Mountain View, CA) FACScan flow
cytometer. Data were analyzed using Cell Quest software
(Becton Dickinson). Suspensions of 200,000 Tregs from
eight C57/Bl6 mice were injected three times into HT
mice in the first week. In the second week, Tregs were
isolated from another group of eight C57/Bl6 mice and
then were injected into HT mice (three times a week).
In Vitro Studies
Tregs were isolated from cell suspensions of spleens
from eight C57Bl/6 mice in two-step procedures. Briefly,
CD4 T cells were pre-enriched by depletion of un-
wanted cells, and then CD25 cells were positively se-
lected from the enriched CD4 T-cell fraction using a
magnetic separation column fitted between a MACS
magnet (Miltenyi Biotech, Sunnyvale, CA). The purity of
CD4CD25 Treg subsets was determined using a fluo-
rescence-activated cell sorter (FACS) and was found to
be greater than 96%. Six-well plates were precoated with
anti-mCD3 (clone 2C11; R&D Systems, Minneapolis,
MN), and the cells were grown in RPMI 1640 medium with
10% fetal bovine serum, 2 mmol/L glutamine, 10 mmol/L
HEPES, 100 U/ml of penicillin, 100 g/ml of streptomycin
(all from Gibco, Invitrogen, Carlsbad, CA), 50 g of
2-mercaptoethanol (Sigma-Aldrich, St. Louis, MO), and
10 ng/ml of human recombinant IL-2 (R&D Systems).
Cells were starved overnight and then were treated for 24
hours with Ang II and Ang II  candesartan (all from
Sigma-Aldrich). The cells were then harvested and sub-
jected to FACS analysis to determine the apoptotic num-
ber of Tregs. Apoptotic Treg levels were determined us-
ing antibodies against fluorochrome-labeled annexin V to
detect exposed phosphatidylserine.
IL-10 Level Measurement
IL-10 measurement was determined in plasma from all
groups according to the manufacturer’s mouse cytokines
(Bio-Plex Assay; Bio-Rad Laboratories, Hercules, CA).
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Mediated dUTP Nick-End Labeling Assay
Briefly, Tregs were stimulated with or without Ang II in the
presence or absence of candesartan. DNA fragmentation
was measured using the DeadEnd colorimetric apoptosis
Figure 1. Effect of long-term Ang II (400 ng/kg/min) infusion with or
without Tregs (200,000 cells) on mean arterial blood pressure as determined
by means of telemetry. *P  0.05, sham versus HT mice; †P  0.05, sham
versus HT  Tregs mice.
Figure 2. A: In vivo number of Tregs in sham, HT, and HT  Tregs mice as
mice. B: In vitro apoptotic Tregs as determined by means of FACS analysis. I
II for 24 hours with or without candesartan (Cand; 10 mol/L) (n  6). *P
transferase-mediated dUTP nick-end labeling assay and cumulative data indic
Ang II versus CTR or Ang II Cand. D, E: Illustrates in vivo Foxp3 staining, and cumu
from sham, HT, and HT  Tregs mice (n  5); negative control represents stainingdetection system according to the manufacturer’s in-
structions (Promega Corp., Madison, WI).
Macrophages
Macrophages were isolated from the peritoneal cavity of
mice using a syringe-gauge device and then were sub-
jected to Western blot analysis.
Immunostaining
The staining protocol was performed using an Au-
tostainer Plus (Dako, Carpenteria, CA). Immunostaining
was performed as previously described.27 The antibod-
ies used were Foxp3-specific antibodies (a marker of
Tregs) and CD68-specific antibodies (a marker of mac-
rophages).
Western Blot Analysis
Western blot analysis was performed as previously de-
scribed.27,29 Isolated coronary arterioles were sonicated
and then subjected to centrifugation for 10 minutes
(10,000  g). The supernatant was collected and sub-
jected to a standard procedure for Western blot analysis.
ned using FACS analysis (n  5). *P  0.05, sham versus HT or HT  Tregs
purified, and cultured Tregs from sham mice were then stimulated with Ang
Ang II versus CTR or Ang II  Cand. C: In vitro terminal deoxynucleotidyl
optotic Tregs under CTR, Ang II, or Cand (10 mol/L) conditions. *P  0.05,determi
solated,
 0.05,
ating aplative data, in green with DAPI nuclear counterstaining in blue of the spleen
using only secondary antibody (n  3). CTR, control.
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Results are expressed as mean  SEM, where n is the
number of arterial segments and cultured cells studied.
The significance of the differences between groups was
determined using one-repeated or two-factor analysis of
variance, where appropriate. Differences were consid-
ered significant at P  0.05.
Results
Eight- to 10-week-old male C57/bl6 mice were random-
ized into three groups: i) normotensive (sham) mice, ii)
HT mice infused with HT doses of Ang II (400 ng/kg/min)
for 2 weeks, and iii) HT mice injected with CD4CD25
Tregs. To assess hypertension, blood pressure was mea-
sured using telemetry (Figure 1). Animals infused with
Ang II displayed elevated blood pressure compared with
the sham group (n  5 to 7). Blood pressure was signifi-
cantly reduced in mice receiving Ang II Tregs (Figure 1).
To determine the reduction in the number of Tregs in
hypertension, we counted isolated and purified Tregs
from the spleens of sham and HT mice using flow cytom-
etry. Our data showed a reduction in the number of Tregs
apoptosis-dependent mechanism in HT compared with
sham mice (Figure 2A). The number of Tregs was similar
in sham mice and in mice receiving Ang II  Tregs
(Figure 2A). To expand our data, we isolated, purified,
and cultured Tregs from the spleen of sham mice and
then stimulated the cells with Ang II (100 nmol/L) for 24
hours. The results revealed an increase in apoptotic
Tregs stimulated with Ang II compared with nonstimu-
lated cells assessed using flow cytometry (Figure 2B).
The increase in the number of apoptotic Tregs in re-
sponse to Ang II was prevented when Tregs were pre-
treated with the AT-1 receptor antagonist (candesartan,
10 mol/L). Figure 2C illustrates the terminal deoxynu-
cleotidyl transferase-mediated dUTP nick-end labeling
assay and quantitative data for Tregs in response to Ang
II with or without candesartan. The data revealed an
increase in apoptotic Treg numbers in response to Ang II,
which was normalized when the cells were pretreated
with candesartan (Figure 2C).
Figure 2D illustrates Foxp3 staining in green with 4-6-
diamidino-2-phenylindole nuclear counterstaining in blue
in the spleen from sham, HT, and HT  Tregs animals.
Foxp3 (a marker of Treg positive) staining was signifi-
cantly reduced in the spleen from HT mice compared
with sham mice. HT mice injected with Tregs had signif-
icantly enhanced Foxp3 staining compared with HT ani-
mals (Figure 2, D and E). The staining was absent in the
negative control, in which we used only secondary anti-
body, indicating the specificity of the staining for Foxp3
(Figure 2D). Figure 3A shows apoptotic Tregs in the
spleen assessed by the ratio of active caspase-3 to
Foxp3 expression. The data revealed an increase in ap-
optotic Treg numbers in HT mice, which was significantly
reduced in sham mice and in HT mice injected with Tregs
(Figure 3A). Secreted anti-inflammatory IL-10 from Tregs
was measured in the plasma from all groups. The datarevealed a significant reduction in IL-10 release in HT
mice compared with sham mice and HT mice injected
with Tregs (Figure 3B). Coronary arterioles from HT mice
displayed a significant increase in the expression of ad-
hesion molecules (intercellular adhesion molecule-1
[ICAM-1] and vascular cell adhesion molecule-1 [VCAM-
1]) compared with sham and HT  Tregs mice (Figure 3,
C and D).
To determine the involvement of macrophages, we iso-
lated macrophages from sham, HT, and HT  Tregs mice
and then subjected them to Western blot analysis for adhe-
sion molecule induction (ICAM-1 and VCAM-1). The data
revealed an increase in ICAM-1 and VCAM-1 expression
Figure 3. A:Western blot analysis and cumulative data of the ratio of Foxp3
to active caspase-3 expression in spleens from sham, HT, and HT  Tregs
mice. -Actin indicates the equal loading between samples (n  6). *P 
0.05, HT versus sham or HT  Tregs mice. B: IL-10 measurement in the
plasma from sham, HT, and HT  Tregs mice (n  6). *P  0.05, HT versus
sham or HT  Tregs mice. C, D: Western blot analysis and quantitative data of
ICAM-1 and VCAM-1 in coronary arterioles from sham, HT, and HT  Tregs
mice. -Actin indicates the equal loading between samples (n  6). *P  0.05,
HT versus sham or HT  Tregs mice.in macrophages from HT mice compared with sham and
es the eq
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the heart from sham, HT, and HT  Tregs mice revealed
an increase in macrophage infiltration into the coronary
arterioles and the heart of HT mice compared with sham
and HT  Tregs mice (Figure 4C). A negative control
(without primary antibody) was performed, and no stain-
ing was detected (data not shown). We measured tumor
necrosis factor (TNF)  in the heart using Western blot
analysis, and the data revealed an increase in TNF- in
HT mice compared with sham and HT  Tregs mice
(Figure 4D). Expression of the chemokine receptor CCR5
in coronary arterioles was significantly increased in HTmice
compared with sham and HT  Tregs mice (Figure 4E).
Endothelial-dependent relaxation in response to ace-
tylcholine was significantly reduced in coronary arterioles
from HT mice compared with sham mice (Figure 5A).
Inhibition of nitric oxide synthesis significantly reduced
the relaxation response to acetylcholine in coronary arte-
rioles from sham mice, and no effect on the response to
acetylcholine was observed in HT mice (Figure 5, A and
B), indicating that the nitric oxide pathway is compro-
mised in HT mice. To extend our hypothesis, we isolated,
purified, and cultured Tregs from sham mice and then
injected the cells into HT mice (200,000 cells three times
a week for 2 weeks). Our data revealed a significant
Figure 4. A: Western blot analysis and cumulative data of ICAM-1 in macro
between samples (n  6). *P  0.05, HT versus sham or HT  Tregs mice. B
HT, and HT  Tregs mice. -Actin indicates the equal loading between sam
macrophage (using CD68 antibody) infiltration into coronary arterioles and th
D: Western blot analysis and cumulative data of TNF- in the heart from sha
(n  6). *P  0.05, HT versus sham or HT  Tregs mice. E: Western blot ana
in coronary arterioles from sham, HT, and HT  Tregs mice. -Actin indicat
Tregs mice.improvement in coronary arteriolar endothelial function(Figure 5C). The inhibition of eNOS significantly reduced
endothelium-dependent relaxation in HT mice injected
with Tregs (Figure 5C). As controls, shams were injected
with Tregs, and no effect was observed on endothelium-
dependent relaxation with or without eNOS inhibition (Figure
5D). Similarly, in HTmice, injection with CD4 T cells did not
affect endothelium-dependent relaxation with or without
eNOS inhibition (Figure 5E). Phosphorylated eNOSwas sig-
nificantly reduced in coronary arterioles from HT mice com-
pared with sham mice (Figure 5D). eNOS phosphorylation
was normalized in coronary arterioles fromHTmice injected
with Tregs (Figure 5D). As a control, we infused HT mice
with vehicle by i.p. injection, and this did not affect endo-
thelial function (data not shown).
Discussion
The critical function of coronary arterioles is to supply
nutrients and oxygen to myocardial tissue; these vessels
also have a significant role in regulating coronary blood
flow. Alterations in coronary arteriolar function are mainly
responsible for heart disease in hypertension. In this
study, we showed that hypertension and coronary arte-
riolar endothelial dysfunction are associated with in-
from sham, HT, and HT  Tregs mice. -Actin indicates the equal loading
n blot analysis and quantitative data of VCAM-1 in macrophages from sham,
 5). *P  0.05, HT versus sham or HT  Tregs mice. C: Staining showing
n sham, HT, and HT Tregs mice. All red points are macrophage infiltration.
and HT  Tregs mice. -Actin indicates the equal loading between samples
cumulative data indicating the expression of the chemokine receptor CCR5
ual loading between samples (n  4). *P  0.05, HT versus sham or HT phages
: Wester
ples (n
e heart i
m, HT,
lysis andcreased apoptotic Treg numbers, a reduction in IL-10
Regulatory T Cells and Coronary Function 439
AJP January 2011, Vol. 178, No. 1content, and the induction of inflammation. The major
finding of the present study is that transfer of Tregs to HT
animals reduced blood pressure and improved coronary
arteriolar endothelial function.
The Treg population is widely accepted as an impor-
tant component of the immune system. Tregs have re-
cently emerged as a key element in the maintenance of a
normal peripheral immune system. These cells play an
indispensable role in maintaining self-tolerance and pro-
tection from autoimmune diseases13–16 and in influencing
the immune response to different pathogens.17 It has
been shown that lymphocytes stimulated by Ang II may
contribute to the pathogenesis of HT kidney injury.19,20
These data indicate the involvement of the immune sys-
tem in the regulation of blood pressure. A recent study
indicated a critical role of Tregs in the inhibition of ath-
erosclerosis in several mouse models.12 Another recent
study showed that a single injection of Tregs ameliorates
hypertension-induced heart damage.24
Hypertension is a “silent” condition and is a major
cause of morbidity and mortality in the world. Microvas-
cular dysfunction plays important roles in the pathogen-
esis of hypertension. The combination of systemic, local
hemodynamic, and humoral factors is responsible for
microvascular homeostasis. Despite the current knowl-
edge of the association between hypertension and vas-
cular complications, cellular and molecular mechanisms
involved in altered coronary arteriolar endothelial function
have yet to be determined. We and other investigatorsdemonstrated a reduction in mesenteric resistance arte-
rial1–4 and coronary arteriolar endothelial-dependent re-
laxation in HT animal models5 resulting from the reduc-
tion in the relaxing factors nitric oxide, prostaglandin I2,
and endothelial-derived hyperpolarizing factor. Evidence
from human and animal models suggests a link between
immune system and cardiovascular pathophysiologic
conditions.30,31 Thus, it is likely that microvascular dys-
function could be the result of perturbation of the immune
system combined with inflammation. Recent evidence
suggests the involvement of inflammation as a critical
pathologic factor in cardiovascular diseases.6–8
In humans, it has been shown that coronary arteriolar
dysfunction is related to smoking behavior, hyperlipid-
emia, diabetes mellitus, microvascular dysfunction, and
hypertension.32–34 Coronary arteriolar dysfunction pre-
disposes to heart disease. Our study showed dysfunction
of coronary arterioles in Ang II–dependent HT mice. Our
data are in agreement with the concept that Tregs play a
critical role in hypertension-induced tissue damage. The
divergence between the two studies is related to the
injection of Tregs.24 In our case, we used injection three
times per week for 2 weeks, and the previous study used
a single injection for 2 weeks.24 Vascular impairment was
assessed by the reduction in endothelial-dependent re-
laxation in coronary arterioles in response to acetylcho-
line compared with the response in sham mice. The in-
cubation of coronary arterioles with nitric oxide synthesis
Figure 5. A: Changes in diameter in response
to dose response (1010 to 105 mol/L) of ace-
tylcholine in coronary arterioles from sham mice
with or without L-NAME (100 mol/L) (n  6).
*P  0.05, sham versus sham  L-NAME mice.
B: Changes in diameter in response to dose
response (1010 to 105 mol/L) of acetylcholine
in coronary arterioles from sham, HT, and HT 
L-NAME mice (n  6). *P  0.05, sham versus
HT mice. C: Changes in diameter in response to
dose response (1010 to 105 mol/L) of acetyl-
choline in coronary arterioles from sham, HT,
and HT  Tregs mice (n  6). *P  0.05, sham
versus HT  Tregs mice; *P  0.05, HT  Tregs
versus HTmice.D: Endothelium-dependent relax-
ation of coronary arterioles from sham mice with
or without L-NAME injected with Tregs (n  6).
*P  0.05, sham/sham  Tregs versus sham 
L-NAME or sham  Tregs  L-NAME mice. E:
Endothelium-dependent relaxation of coronary
arterioles from HT mice with or without L-NAME
injected with CD4 T cells (n  7). F: Western
blot analysis and cumulative data of phospho-
rylated and total eNOS in coronary arterioles
from sham, HT, and HT  Tregs mice. -Actin
indicates the equal loading between samples (n
 5). *P  0.05, HT mice versus sham or HT 
Tregs mice.inhibitor (L-NAME) significantly reduced the relaxation of
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tylcholine in sham mice, and no effect was observed in
coronary arterioles from HT mice. These data indicate
that the eNOS pathway is compromised, which is in
agreement with previous studies.1,32 The inhibition of
eNOS significantly reduced endothelium-dependent re-
laxation in HT mice injected with Tregs, indicating the
effect of Tregs on the eNOS pathway. As controls, shams
were injected with Tregs, and no effect was observed on
endothelium-dependent relaxation with or without eNOS
inhibition. In addition, in HT mice, injection with CD4 T
cells did not affect endothelium-dependent relaxation
with or without eNOS inhibition. These data indicate the
specific effect of Tregs on endothelium-dependent relax-
ation through the eNOS pathway. To extend our data, we
performed Western blot analysis on coronary arterioles
from sham and HT mice. The data revealed a decrease in
eNOS phosphorylation in coronary arterioles from HT
mice compared with sham mice.
Our data showed that Ang II–dependent hypertension
is associated with significantly reduced numbers of Tregs
compared with sham. The reduction in Treg numbers was
due to apoptosis as determined by FACS analysis. To
extend our study, we performed Western blot analysis,
and the data revealed that the ratio of Foxp3 to active
caspase-3 was significantly reduced in the spleen from
HT mice compared with sham and HT  Tregs mice.
These data provide evidence of an important association
between the reduction in Treg numbers and the impair-
ment of coronary arteriolar endothelial function in Ang
II–dependent hypertension. To extend our study, we iso-
lated, purified, and cultured Tregs from sham animals
and then stimulated the cells with Ang II for 24 hours.
Cultured Tregs stimulated with Ang II for 24 hours dis-
played significantly increased apoptotic Treg numbers
as assessed by FACS analysis. The increased apoptotic
Treg numbers in response to Ang II stimulation were
significantly reduced when Tregs were pretreated with
candesartan. These data suggest that increased apop-
totic Treg numbers in hypertension could be the trigger
for the onset of hypertension and vascular complications.
To determine the link between the reduction in the num-
ber of Tregs and hypertension and coronary arteriolar
endothelial dysfunction, we injected HT mice with Tregs
isolated from sham animals. Mice receiving Ang II 
Tregs displayed a significant reduction in blood pressure
(not reaching the control level) and an improvement in
coronary arteriolar endothelial function. These data are
not in agreement with those of a previous study showing
the involvement of T cells in blood pressure regulation
and aorta smooth muscle function in Rag1/ mice.21
These divergence results could be related to the animal
model used because Rag1/ mice are susceptible to
type 1 diabetes mellitus, loss of weight, and compro-
mised physiologic function related to T and B cells. On
the other hand, our data are in agreement with the con-
cept that cardiovascular injury is linked to Tregs. Thus,
the single injection of Tregs reduces hypertension-in-
duced cardiac damage independently of the blood pres-
sure–lowering effect.24 One explanation regarding dis-
crepancies in blood pressure would be the fact that micereceived Tregs three times a weeks for 2 weeks rather
than a single injection.
To further delineate the mechanism of how a reduction
in Treg numbers triggers coronary arteriolar endothelial
dysfunction in hypertension, we examined the role of
inflammation. Recent studies reported that inflammation
is critical in the pathogenesis of cardiovascular diseas-
es.6,8 Thus, in our study, we suggested that the reduction
in IL-10 release is associated with increased macro-
phage activity assessed by the up-regulation of adhesion
molecule (ICAM-1 and VCAM-1) expression in HT ani-
mals. HT mice injected with Tregs displayed significantly
increased IL-10 content associated with the reduction in
ICAM-1 and VCAM-1 expression on macrophages. We
also found that coronary arterioles from HT mice display
an increase in ICAM-1 and VCAM-1 expression, which
facilitates macrophage infiltration into coronary arterioles
and the heart. It has been reported that chemokine re-
ceptors are also important in the infiltration of macro-
phages.35 In this study, we found an increase in the
expression of CCR5 in coronary arterioles from HT mice
compared with sham and HT  Tregs mice. These data
indicate that macrophage infiltration into coronary arte-
rioles and the heart could be facilitated by the increase in
CCR5 expression in hypertension.
We also found a large number of infiltrated macro-
phages associated with increased levels of TNF- in the
heart of HT mice compared with sham mice. HT mice
infused with purified Tregs display significant reductions
in macrophage activity and infiltration and TNF- levels
compared with HT mice. These data indicate that the
reduction in Treg numbers leads to inflammation, which,
in turn, is responsible for endothelium-dependent relax-
ation dysfunction and sustained hypertension. It is well-
known that an increased TNF- level contributes to en-
dothelial dysfunction.36 TNF- knockout mice infused
with Ang II do not develop high blood pressure, indicat-
ing the critical role of TNF- in the regulation of blood
pressure.37 It is well-known that Ang II has a broad effect
on different organs, such as the heart, kidneys, brain, and
vasculature, to develop blood pressure. Based on our
data, Tregs significantly participate in the effect of Ang II
on coronary function and blood pressure, but still we do
not know the in vivo link between Ang II effects, Tregs,
and other organs for the development of blood pressure.
In conclusion, we showed that the Treg population,
termed natural regulatory cells and known to be crucial in
the maintenance of peripheral tolerance, has an impor-
tant role in coronary arteriolar endothelial dysfunction and
hypertension. These results identify a new target for the
modulation of hypertension and coronary arteriolar dys-
function and may provide new insight into potential
mechanisms relating autoimmune and coronary arteriolar
disease and hypertension.
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